Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Mehdi Touat, M.D.

Concepts (231)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Brain Neoplasms23202285901.860 Why?
Glioma9202131101.370 Why?
Isocitrate Dehydrogenase820207610.990 Why?
Oligodendroglioma320202820.920 Why?
Myositis320192170.920 Why?
Glioblastoma8202232710.850 Why?
Ganglioglioma22021460.800 Why?
Multiple Acyl Coenzyme A Dehydrogenase Deficiency1201880.760 Why?
Azacitidine120202910.750 Why?
Riboflavin120181030.720 Why?
Azetidines220211530.710 Why?
Drug Resistance, Bacterial3202110780.670 Why?
Molecular Targeted Therapy5201828840.620 Why?
Aftercare120215370.620 Why?
Hospital Costs2202110190.600 Why?
Mutation112021288480.580 Why?
Receptors, Fibroblast Growth Factor120151800.560 Why?
Hormone Antagonists120141180.540 Why?
Neurotoxicity Syndromes120172640.540 Why?
NAD120185870.540 Why?
Mifepristone120141300.530 Why?
Corpus Callosum120186970.510 Why?
Bacterial Infections2201914370.510 Why?
Astrocytoma220217770.500 Why?
Apoptosis Regulatory Proteins1201811400.500 Why?
Myocarditis120186220.490 Why?
Antineoplastic Agents92020138980.460 Why?
Immunotherapy2201737930.460 Why?
Lymphoma1202118630.460 Why?
Neoplasms, Experimental1201814160.460 Why?
Piperidines2202115120.440 Why?
Genetic Heterogeneity120157600.430 Why?
Medical Oncology1202118820.400 Why?
Proto-Oncogene Proteins B-raf4202118850.390 Why?
Receptors, Progesterone1201411120.380 Why?
Brain Diseases1201815450.380 Why?
Length of Stay2202162410.370 Why?
Patient Discharge1202127540.370 Why?
DNA Repair1201820350.350 Why?
Immunologic Factors1201714770.350 Why?
DNA Mismatch Repair220213760.340 Why?
Anti-Bacterial Agents3202168290.330 Why?
France420214920.320 Why?
Antineoplastic Agents, Alkylating220216340.310 Why?
Cytokines2201871470.310 Why?
Neoplasms42018195380.310 Why?
Meningioma1201411280.310 Why?
Antineoplastic Combined Chemotherapy Protocols22018111150.300 Why?
Meningeal Neoplasms1201411470.300 Why?
Evolution, Molecular1201520320.300 Why?
Hospitalization4202193040.280 Why?
Carcinoma, Renal Cell2201729110.270 Why?
Protein Kinase Inhibitors3202152520.260 Why?
Drug Resistance, Neoplasm1201852650.240 Why?
Kidney Neoplasms2201740170.240 Why?
Phenotype22020160910.220 Why?
Lomustine12020640.220 Why?
Humans4620226866630.220 Why?
Leukoencephalopathy, Progressive Multifocal120221430.220 Why?
Histiocytosis, Sinus12021490.220 Why?
Carcinoma, Non-Small-Cell Lung1201846170.200 Why?
Single-Cell Analysis2202120480.200 Why?
Cell Size120216780.190 Why?
Stereotaxic Techniques120215310.190 Why?
Neoplasms, Neuroepithelial12019510.190 Why?
Bacteria2202119980.180 Why?
Vincristine1202010320.180 Why?
Mitogen-Activated Protein Kinase Kinases120215880.180 Why?
Phosphatidylinositol 3-Kinase120191290.180 Why?
Aneuploidy120214610.180 Why?
Receptors, Cholinergic120181970.180 Why?
Receptors, Somatostatin120181230.180 Why?
Nicotinamide Phosphoribosyltransferase12018930.170 Why?
Microsatellite Repeats120208270.170 Why?
Microsatellite Instability120216790.170 Why?
Glycine120206710.160 Why?
Receptor, Fibroblast Growth Factor, Type 1120182570.160 Why?
Chromosomes, Human, Pair 19120183780.160 Why?
Central Nervous System2202112160.160 Why?
Deltoid Muscle12016130.160 Why?
Glutarates120182240.160 Why?
Creatine Kinase120187220.160 Why?
Mesencephalon120183240.160 Why?
Meningitis120172170.150 Why?
Mutagenesis1202013120.150 Why?
Adult2020212114000.150 Why?
Morpholines120195940.150 Why?
Urinary Tract Infections120217590.150 Why?
Chromosomes, Human, Pair 1120186970.150 Why?
Aminopyridines120195080.140 Why?
Radiculopathy120171870.140 Why?
Endonucleases120183720.140 Why?
Lung Neoplasms22018120090.140 Why?
Signal Transduction22017243510.140 Why?
Male2220213524650.140 Why?
Optic Nerve Diseases120173150.130 Why?
Retrospective Studies92021673200.130 Why?
Xenograft Model Antitumor Assays2202038810.130 Why?
Chromosome Deletion1201813850.130 Why?
Mice, Nude2201840400.130 Why?
Electromyography1201813820.120 Why?
Quinoxalines120152950.120 Why?
Middle Aged1820212164680.120 Why?
Muscle, Skeletal2201949600.120 Why?
Bile Duct Neoplasms120185510.120 Why?
Aged1620211622710.120 Why?
Cholangiocarcinoma120185030.120 Why?
Gene Frequency1202037130.120 Why?
Microfluidic Analytical Techniques120187310.120 Why?
RNA, Viral1202128230.120 Why?
Clinical Trials as Topic3202180700.120 Why?
Europe1201832770.110 Why?
Female2220213754590.110 Why?
Aged, 80 and over82021593310.110 Why?
Receptor Protein-Tyrosine Kinases1201816160.100 Why?
Karnofsky Performance Status220211930.100 Why?
Antibodies, Monoclonal2201898630.100 Why?
Biological Products120177180.100 Why?
Autoantibodies1201819250.100 Why?
DNA Modification Methylases220212060.100 Why?
DNA, Neoplasm1201518670.090 Why?
Inpatients1201920500.090 Why?
Insurance, Health1202124790.090 Why?
Cerebral Amyloid Angiopathy120157040.090 Why?
High-Throughput Nucleotide Sequencing1202135570.090 Why?
Neoplastic Cells, Circulating120158680.090 Why?
Prognosis52020289230.090 Why?
Neoadjuvant Therapy1201924030.090 Why?
Predictive Value of Tests22021154070.090 Why?
Sequence Analysis, DNA1202050440.090 Why?
DNA Repair Enzymes220213730.090 Why?
Pyridines1202028430.090 Why?
Autoimmune Diseases1201920920.080 Why?
Gene Expression Regulation, Neoplastic3201888950.080 Why?
Software1202143140.080 Why?
Young Adult82020560520.080 Why?
Genome, Human1202044580.080 Why?
Oncogene Proteins, Fusion1201515480.080 Why?
Treatment Outcome52020609910.070 Why?
Mice42020808030.070 Why?
Randomized Controlled Trials as Topic1202193370.070 Why?
Case-Control Studies22021216840.070 Why?
Myocardium1201850240.070 Why?
Neoplasm Proteins1201839720.070 Why?
Evidence-Based Medicine1201737970.070 Why?
Magnetic Resonance Imaging42020331860.070 Why?
Pyrazoles1201519070.070 Why?
Neovascularization, Pathologic1201527670.070 Why?
Animals520201708490.070 Why?
Neoplasm Recurrence, Local2201986100.060 Why?
Colorectal Neoplasms1202163230.060 Why?
raf Kinases120211200.060 Why?
T-Lymphocytes12019103290.050 Why?
Algorithms12021135000.050 Why?
Adolescent52019849570.050 Why?
DNA-Binding Proteins1201899340.050 Why?
MAP Kinase Kinase Kinases120212810.050 Why?
Oximes120213120.050 Why?
Quality of Health Care1201543030.050 Why?
Follow-Up Studies22018397370.050 Why?
Tumor Suppressor Proteins2202129020.050 Why?
MicroRNAs1201535870.050 Why?
Pyrimidinones120213540.050 Why?
Drug Screening Assays, Antitumor120217770.050 Why?
Isomerism120182210.040 Why?
Reproducibility of Results32021193080.040 Why?
Melanoma1201655050.040 Why?
DNA Polymerase II120181130.040 Why?
Myositis, Inclusion Body120191400.040 Why?
DNA Mutational Analysis2201844150.040 Why?
Tissue Array Analysis120185940.040 Why?
Pyridones120216390.040 Why?
Cohort Studies12019387320.040 Why?
Ki-67 Antigen120186350.040 Why?
DNA Methylation2202139870.040 Why?
Kaplan-Meier Estimate2201869700.040 Why?
Documentation120218060.040 Why?
Inflammation1201596170.040 Why?
Receptor, Fibroblast Growth Factor, Type 3120151190.030 Why?
Drug Substitution120173000.030 Why?
Imidazoles1202112880.030 Why?
Mitogen-Activated Protein Kinases1201913720.030 Why?
Immunohistochemistry22021120950.030 Why?
Databases, Genetic1202118180.030 Why?
Clinical Trials, Phase I as Topic120153240.030 Why?
Information Services120152450.030 Why?
Survival Rate22021136060.030 Why?
Genome1202116810.030 Why?
Internationality1201810110.030 Why?
Brain22021242020.030 Why?
Clinical Trials, Phase II as Topic120156160.030 Why?
Enzyme Activation1201939690.030 Why?
Necrosis1201616640.030 Why?
Statistics, Nonparametric1201830090.030 Why?
Drug Prescriptions1202116830.030 Why?
Chemotherapy, Adjuvant1201934860.030 Why?
Fluorescent Antibody Technique1201527720.030 Why?
Equipment Design1201836530.030 Why?
Tumor Cells, Cultured1201868350.020 Why?
Neoplasm Invasiveness1201837890.020 Why?
Promoter Regions, Genetic1202161500.020 Why?
Microtubule-Associated Proteins1201511050.020 Why?
Biopsy1202168490.020 Why?
Drug Administration Schedule1201751820.020 Why?
Enzyme Inhibitors1202039980.020 Why?
Radiotherapy Dosage1201529910.020 Why?
International Cooperation1201515000.020 Why?
Disease-Free Survival1201871950.020 Why?
Dose-Response Relationship, Drug12020116160.020 Why?
Lipids1201831310.020 Why?
Reverse Transcriptase Polymerase Chain Reaction1201551140.020 Why?
Hospitals1201929300.020 Why?
Child, Preschool22019411590.020 Why?
Genomics1202149210.020 Why?
Neoplasm Metastasis1201753910.020 Why?
Databases, Factual1202178650.020 Why?
Survival Analysis12018107660.020 Why?
Models, Biological12021101020.020 Why?
Multivariate Analysis12018127340.020 Why?
Neoplasm Staging12018112650.020 Why?
Cell Line12018171370.020 Why?
Disease Progression12019132040.010 Why?
Cells, Cultured12018206200.010 Why?
Incidence12019204960.010 Why?
Infant, Newborn12019239530.010 Why?
Prospective Studies12021490710.010 Why?
Infant12019339180.010 Why?
Risk Assessment12018237390.010 Why?
Time Factors12019422710.010 Why?
Risk Factors12021692780.010 Why?
Child12019713610.010 Why?
Touat's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (231)
Explore
_
Co-Authors (44)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.